<SEC-DOCUMENT>0000899243-19-010901.txt : 20190418
<SEC-HEADER>0000899243-19-010901.hdr.sgml : 20190418
<ACCEPTANCE-DATETIME>20190418171533
ACCESSION NUMBER:		0000899243-19-010901
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20190418
FILED AS OF DATE:		20190418
DATE AS OF CHANGE:		20190418

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Edwards Lifesciences Holding, Inc.
		CENTRAL INDEX KEY:			0001767918
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-13839
		FILM NUMBER:		19756620

	BUSINESS ADDRESS:	
		STREET 1:		ONE EDWARDS WAY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		9492502500

	MAIL ADDRESS:	
		STREET 1:		ONE EDWARDS WAY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Edwards Lifesciences Corp
		CENTRAL INDEX KEY:			0001099800
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-13839
		FILM NUMBER:		19756621

	BUSINESS ADDRESS:	
		STREET 1:		ONE EDWARDS WAY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		9492502500

	MAIL ADDRESS:	
		STREET 1:		ONE EDWARDS WAY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614

	FORMER NAME:	
		FORMER CONFORMED NAME:	EDWARDS LIFESCIENCES CORP.
		DATE OF NAME CHANGE:	20090225

	FORMER NAME:	
		FORMER CONFORMED NAME:	EDWARDS LIFESCIENCES CORP
		DATE OF NAME CHANGE:	20000203

	FORMER NAME:	
		FORMER CONFORMED NAME:	CVG CONTROLLED INC
		DATE OF NAME CHANGE:	19991126

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CAS MEDICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000764579
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				061123096
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		44 EAST INDUSTRIAL ROAD
		CITY:			BRANFORD
		STATE:			CT
		ZIP:			06405
		BUSINESS PHONE:		2034886056

	MAIL ADDRESS:	
		STREET 1:		44 EAST INDUSTRIAL ROAD
		CITY:			BRANFORD
		STATE:			CT
		ZIP:			06405
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2019-04-18</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000764579</issuerCik>
        <issuerName>CAS MEDICAL SYSTEMS INC</issuerName>
        <issuerTradingSymbol>CASM</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001767918</rptOwnerCik>
            <rptOwnerName>Edwards Lifesciences Holding, Inc.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>ONE EDWARDS WAY</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>IRVINE</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>92614</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001099800</rptOwnerCik>
            <rptOwnerName>Edwards Lifesciences Corp</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>ONE EDWARDS WAY</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>IRVINE</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>92614</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock, $0.004 par value per share</value>
            </securityTitle>
            <transactionDate>
                <value>2019-04-18</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>J</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>40049789</value>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                    <footnoteId id="F3"/>
                </transactionShares>
                <transactionPricePerShare>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>40049789</value>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                    <footnoteId id="F3"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">On April 18, 2019, pursuant to the Agreement and Plan of Merger, dated as of February 11, 2019 (the &quot;Merger Agreement&quot;), by and among Edwards Lifesciences Holding, Inc., a Delaware corporation and a wholly owned subsidiary of Edwards Lifesciences Corporation (&quot;Acquiror&quot;), Crown Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Acquiror (&quot;Merger Sub&quot;) and CAS Medical Systems, Inc. a Delaware corporation (&quot;Issuer&quot;), Merger Sub merged with and into Issuer, with Issuer as the surviving corporation and a wholly owned subsidiary of the Acquiror (the &quot;Merger&quot;).</footnote>
        <footnote id="F2">Pursuant to the Merger Agreement, at the effective time of the Merger (the &quot;Effective Time&quot;), each share of common stock, par value $0.004 per share, of Issuer (the &quot;Issuer Common Stock&quot;) issued and outstanding immediately prior to the Effective Time (other than shares of Issuer Common Stock owned by the Issuer as treasury stock or owned directly by the Acquiror or any of its subsidiaries (including Merger Sub) or shares of Issuer Common Stock the holders of which properly perfected their appraisal rights under Delaware law), which totaled 40,049,789 shares, was cancelled and converted into the right to receive $2.45 per share in cash, without interest or dividends thereon.</footnote>
        <footnote id="F3">In connection with entering into the Merger Agreement, certain stockholders of the Issuer (collectively, the &quot;Subject Stockholders&quot;) entered into voting agreements (the &quot;Voting Agreements&quot;) with Acquiror pursuant to which the Subject Stockholders agreed, among other things, to vote their Issuer securities, including shares of Issuer Common Stock, preferred stock of the Issuer and options (collectively the &quot;Voting Agreement Shares&quot;) in favor of the Merger.  On February 21, 2019, Acquiror and Edwards Lifesciences Corporation (&quot;Edwards&quot;) jointly filed a Form 3 with respect to the Voting Agreement Shares; however, in such filing, Acquiror and Edwards Lifesciences Corporation disclaimed any &quot;pecuniary interest&quot; or beneficial ownership interests in such securities.  Upon the Effective Time, each of the Voting Agreements terminated by its terms.</footnote>
    </footnotes>

    <remarks>Item 1 of this Form 4 includes only the name and address of Acquiror, as designated filer pursuant to Instruction 4(b)(v) to Form 4.  The name and address of Edwards, as joint filer, is as follows:
Edwards Lifesciences Corporation
One Edwards Way
Irvine, CA 92614</remarks>

    <ownerSignature>
        <signatureName>Edwards Lifesciences Corporation, By: /s/ Scott B. Ullem</signatureName>
        <signatureDate>2019-04-18</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>Edwards Lifesciences Holding, Inc., By: /s/ Scott B. Ullem</signatureName>
        <signatureDate>2019-04-18</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
